parthenolide has been researched along with ciclopirox in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, MW; Corbett, C; Guzman, ML; Hassane, DC; Jordan, CT; Sen, S | 1 |
1 trial(s) available for parthenolide and ciclopirox
| Article | Year |
|---|---|
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cell Line, Tumor; Ciclopirox; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Pyridones; Sesquiterpenes; TOR Serine-Threonine Kinases | 2013 |